Lyell Immunopharma, Inc. (LYEL) revenue

Revenue · fiscal 2025
$36.00K

Lyell Immunopharma, Inc. (LYEL) reported revenue of $36.00K in fiscal 2025 (the year ended December 31, 2025). That is 41.0% lower than the $61.00K of fiscal 2024. Figures as of 18 Nov 2026, 13:09 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$36.00K
Change on fiscal 2024
−41.0%
Growth, 5 years
−65.9% a year
Highest on record
$84.68Mfiscal 2022
Lowest on record
$36.00Kfiscal 2025
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Lyell Immunopharma, Inc. revenue, in more detail

Over the five fiscal years to 2025 revenue shrank at a compound 65.9% a year. Across the 7 fiscal years on record (2019–2025), the highest was $84.68M in fiscal 2022 and the lowest $36.00K in fiscal 2025.

History · 7 fiscal years

Revenue by fiscal year

Lyell Immunopharma, Inc. revenue, year by year

Lyell Immunopharma, Inc. (LYEL) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$36.00K 41.0% down
2024$61.00K 53.1% down
2023$130.00K 99.8% down
2022$84.68M 695.1% up
2021$10.65M 37.3% up
2020$7.76M 1,080.5% up
2019$657.00K—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on LYEL

Lyell Immunopharma, Inc., figure by figure

Lyell Immunopharma, Inc. (LYEL) overview: price, valuation and scorecard

Lyell Immunopharma, Inc. revenue: questions and answers

What is Lyell Immunopharma, Inc.'s revenue?

Lyell Immunopharma, Inc. (LYEL) reported revenue of $36.00K in fiscal 2025 (the year ended December 31, 2025). That is 41.0% lower than the $61.00K of fiscal 2024.

What is the growth rate of Lyell Immunopharma, Inc.'s revenue?

Over the five fiscal years to 2025 revenue shrank at a compound 65.9% a year.

What are the highest and lowest revenue figures on record for Lyell Immunopharma, Inc.?

Across the 7 fiscal years on record (2019–2025), the highest was $84.68M in fiscal 2022 and the lowest $36.00K in fiscal 2025.

How is Lyell Immunopharma, Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Lyell Immunopharma, Inc. it is on record here for 7 fiscal years, 2019 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Lyell Immunopharma, Inc. (LYEL) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/LYEL/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.